Skip Header

Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q62432 (SMAD2_MOUSE)

Last modified February 9, 2010. Version 108. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (2) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Mothers against decapentaplegic homolog 2
      Short name=Mothers against DPP homolog 2
      Short name=MAD homolog 2
Alternative name(s):
    Mad-related protein 2
      Short name=mMad2
    SMAD 2
Gene names
Name: Smad2
Synonyms: Madh2, Madr2
OrganismMus musculus (Mouse)
Taxonomic identifier10090 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeMus

Protein attributes

Sequence length467 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Transcriptional modulator activated by TGF-beta and activin type 1 receptor kinase. SMAD2 is a receptor-regulated SMAD (R-SMAD). Required for gastrulation.

Subunit structure

Found in a complex with SMAD3 and TRIM33 upon addition of TGF-beta. Interacts with SMAD3 and TRIM33. Interacts with SARA (SMAD anchor for receptor activation); may form trimers with the SMAD4 co-SMAD. Interacts with FOXH1, homeobox protein TGIF, PEBP2-alpha subunit, CREB-binding protein (CBP), EP300 and SKI. Interacts with SNON; when phosphorylated at Ser-465/467. Interacts (via PY-motif) with SMURF2. Interacts with LBXCOR1 and CORL2. Interacts with PRDM16. Interacts (via MH2 domain) with LEMD3. Interacts with RBPMS; the interaction is direct By similarity. Interacts with AIP1 and HGS. Interacts with NEDD4L in response to TGF-beta. Ref.9 Ref.10 Ref.11

Subcellular location

Cytoplasm. Nucleus. Note: Cytoplasmic in the absence of ligand. Migrates to the nucleus when complexed with SMAD4.

Post-translational modification

In response to TGF-beta, phosphorylated on Ser-465/467 by TGF-beta and activin type 1 receptor kinases. Able to interact with SMURF2 when phosphorylated on Ser-465/467, recruiting other proteins, such as SNON, for degradation. In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, phosphorylated on Ser-240 by CaMK2. Phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin By similarity. Ref.8

In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, phosphorylated on Ser-240 by CaMK2. Phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin By similarity. Ref.8

In response to TGF-beta, ubiquitinated by NEDD4L; which promotes its degradation.

Acetylated on Lys-19 by coactivators in response to TGF-beta signaling, which increases transcriptional activity By similarity.

Sequence similarities

Belongs to the dwarfin/SMAD family.

Contains 1 MH1 (MAD homology 1) domain.

Contains 1 MH2 (MAD homology 2) domain.

Ontologies

Keywords
   Biological processTranscription
Transcription regulation
   Cellular componentCytoplasm
Nucleus
   Coding sequence diversityAlternative splicing
   PTMAcetylation
Phosphoprotein
Ubl conjugation
Gene Ontology (GO)
   Biological processanterior/posterior pattern formation

Inferred from mutant phenotype. Source: MGI

cell fate commitment

Inferred from mutant phenotype. Source: MGI

developmental growth

Inferred from genetic interaction. Source: MGI

embryonic cranial skeleton morphogenesis

Inferred from genetic interaction. Source: MGI

embryonic foregut morphogenesis

Inferred from genetic interaction. Source: MGI

endoderm development

Inferred from genetic interaction. Source: MGI

heart development

Inferred from genetic interaction. Source: MGI

in utero embryonic development

Inferred from mutant phenotype. Source: MGI

insulin secretion

Inferred from genetic interaction. Source: MGI

intracellular signaling cascade

Inferred from direct assay. Source: MGI

lung development

Inferred from genetic interaction. Source: MGI

mesoderm formation

Inferred from mutant phenotype. Source: MGI

organ growth

Inferred from genetic interaction. Source: MGI

palate development

Inferred from mutant phenotype. Source: UniProtKB

pancreas development

Inferred from genetic interaction. Source: MGI

paraxial mesoderm morphogenesis

Inferred from mutant phenotype. Source: MGI

pericardium development

Inferred from genetic interaction. Source: MGI

positive regulation of epithelial to mesenchymal transition

Inferred from mutant phenotype. Source: UniProtKB

positive regulation of gene-specific transcription

Inferred from mutant phenotype. Source: UniProtKB

positive regulation of transcription from RNA polymerase II promoter

Inferred from direct assay. Source: MGI

post-embryonic development

Inferred from genetic interaction. Source: MGI

protein amino acid phosphorylation

Inferred from direct assay. Source: MGI

regulation of binding

Inferred from direct assay. Source: MGI

response to glucose stimulus

Inferred from genetic interaction. Source: MGI

transcription

Inferred from electronic annotation. Source: UniProtKB-KW

transforming growth factor beta receptor signaling pathway

Inferred from direct assay. Source: MGI

ureteric bud development

Inferred from expression pattern. Source: UniProtKB

   Cellular componentcytoplasm

Inferred from direct assay. Source: UniProtKB

   Molecular functionchromatin binding

Inferred from direct assay. Source: MGI

double-stranded DNA binding

Inferred from direct assay. Source: MGI

transcription activator activity

Inferred from direct assay. Source: MGI

transcription factor activity

Inferred from electronic annotation. Source: InterPro

transcription factor binding

Inferred from physical interaction. Source: UniProtKB

Complete GO annotation...

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]

Note: mRNA corresponding to the isoform Long is approximately 20-fold more abundant. Both forms are coexpressed throughout mouse development.
Isoform Long (identifier: Q62432-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform Short (identifier: Q62432-2)

Also known as: Deltaexon3;

The sequence of this isoform differs from the canonical sequence as follows:
     79-108: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Initiator methionine11Removed By similarity
Chain2 – 467466Mothers against decapentaplegic homolog 2
PRO_0000090853

Regions

Domain10 – 176167MH1
Domain274 – 467194MH2
Motif221 – 2255PY-motif By similarity

Amino acid modifications

Modified residue21N-acetylserine By similarity
Modified residue81Phosphothreonine By similarity
Modified residue191N6-acetyllysine By similarity
Modified residue2401Phosphoserine; by CAMK2 By similarity
Modified residue4581Phosphoserine By similarity
Modified residue4651Phosphoserine Ref.8
Modified residue4671Phosphoserine Ref.8

Natural variations

Alternative sequence79 – 10830Missing in isoform Short.
VSP_021571

Experimental info

Sequence conflict421E → Q Ref.1
Sequence conflict421E → Q Ref.2

Sequences

Sequence LengthMass (Da)Tools
Isoform Long [UniParc].

Last modified November 14, 2006. Version 2.
Checksum: 31A2A36D463DB3E9

FASTA46752,266
        10         20         30         40         50         60 
MSSILPFTPP VVKRLLGWKK SAGGSGGAGG GEQNGQEEKW CEKAVKSLVK KLKKTGRLDE 

        70         80         90        100        110        120 
LEKAITTQNC NTKCVTIPST CSEIWGLSTA NTVDQWDTTG LYSFSEQTRS LDGRLQVSHR 

       130        140        150        160        170        180 
KGLPHVIYCR LWRWPDLHSH HELKAIENCE YAFNLKKDEV CVNPYHYQRV ETPVLPPVLV 

       190        200        210        220        230        240 
PRHTEILTEL PPLDDYTHSI PENTNFPAGI EPQSNYIPET PPPGYISEDG ETSDQQLNQS 

       250        260        270        280        290        300 
MDTGSPAELS PTTLSPVNHS LDLQPVTYSE PAFWCSIAYY ELNQRVGETF HASQPSLTVD 

       310        320        330        340        350        360 
GFTDPSNSER FCLGLLSNVN RNATVEMTRR HIGRGVRLYY IGGEVFAECL SDSAIFVQSP 

       370        380        390        400        410        420 
NCNQRYGWHP ATVCKIPPGC NLKIFNNQEF AALLAQSVNQ GFEAVYQLTR MCTIRMSFVK 

       430        440        450        460 
GWGAEYRRQT VTSTPCWIEL HLNGPLQWLD KVLTQMGSPS VRCSSMS 

« Hide

Isoform Short (Deltaexon3).

Checksum: 0E2FF38B009D2F9E
Show »

FASTA43748,956

References

« Hide 'large scale' references
[1]"A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway."
Baker J.C., Harland R.M.
Genes Dev. 10:1880-1889(1996) [PubMed: 8756346] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
Strain: 129/Sv.
[2]"Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1): candidates for murine lung tumor resistance and suppressor genes."
Devereux T.R., Anna C.H., Patel A.C., White C.M., Festing M.F., You M.
Carcinogenesis 18:1751-1755(1997) [PubMed: 9328171] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
Strain: A/J and BALB/c.
[3]"Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells."
Bernard D.J.
Mol. Endocrinol. 18:606-623(2004) [PubMed: 14701940] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT).
[4]"The transcriptional landscape of the mammalian genome."
Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. expand/collapse author list , Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.
Science 309:1559-1563(2005) [PubMed: 16141072] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
Strain: C57BL/6J.
Tissue: Pancreas.
[5]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
[6]"Functions of mammalian Smad genes as revealed by targeted gene disruption in mice."
Weinstein M., Yang X., Deng C.-X.
Cytokine Growth Factor Rev. 11:49-58(2000) [PubMed: 10708952] [Abstract]
Cited for: REVIEW.
[7]"Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile."
Dunn N.R., Koonce C.H., Anderson D.C., Islam A., Bikoff E.K., Robertson E.J.
Genes Dev. 19:152-163(2005) [PubMed: 15630024] [Abstract]
Cited for: ALTERNATIVE SPLICING (ISOFORM SHORT).
[8]"Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation."
Haller D., Holt L., Kim S.C., Schwabe R.F., Sartor R.B., Jobin C.
J. Biol. Chem. 278:23851-23860(2003) [PubMed: 12672795] [Abstract]
Cited for: PHOSPHORYLATION AT SER-465 AND SER-467.
[9]"Identification and characterization of a PDZ protein that interacts with activin types II receptors."
Shoji H., Tsuchida K., Kishi H., Yamakawa N., Matsuzaki T., Liu Z., Nakamura T., Sugino H.
J. Biol. Chem. 275:5485-5492(2000) [PubMed: 10681527] [Abstract]
Cited for: INTERACTION WITH AIP1.
[10]"Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA."
Miura S., Takeshita T., Asao H., Kimura Y., Murata K., Sasaki Y., Hanai J., Beppu H., Tsukazaki T., Wrana J.L., Miyazono K., Sugamura K.
Mol. Cell. Biol. 20:9346-9355(2000) [PubMed: 11094085] [Abstract]
Cited for: INTERACTION WITH HGS.
[11]"NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor."
Kuratomi G., Komuro A., Goto K., Shinozaki M., Miyazawa K., Miyazono K., Imamura T.
Biochem. J. 386:461-470(2005) [PubMed: 15496141] [Abstract]
Cited for: INTERACTION WITH NEDD4L, UBIQUITINATION.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
U60530 mRNA. Translation: AAB03612.1.
AF005743 mRNA. Translation: AAB62269.1.
AK007817 mRNA. Translation: BAB25282.1.
AY334552 mRNA. Translation: AAR00933.1.
BC021342 mRNA. Translation: AAH21342.1.
BC089184 mRNA. Translation: AAH89184.1.
IPIIPI00458087.
IPI00556692.
RefSeqNP_034884.2.
UniGeneMm.391091

3D structure databases

SMRQ62432. Positions 7-172, 265-467.
ModBaseSearch...

Protein-protein interaction databases

STRINGQ62432.

PTM databases

PhosphoSiteQ62432.

Proteomic databases

PRIDEQ62432.

Genome annotation databases

EnsemblENSMUST00000025453; ENSMUSP00000025453; ENSMUSG00000024563; Mus musculus. [Genome view]
ENSMUST00000091831; ENSMUSP00000089439; ENSMUSG00000024563; Mus musculus. [Genome view]
GeneID17126.
KEGGmmu:17126.
UCSCuc008fqn.1. mouse.
uc008fqo.1. mouse.

Organism-specific databases

CTD17126.
MGIMGI:108051. Smad2.

Phylogenomic databases

eggNOGroNOG12697.
HOGENOMHBG443554.
HOVERGENQ62432.
InParanoidQ62432.
OMAWKKSASG.
OrthoDBEOG9DRCZ7.
PhylomeDBQ62432.

Gene expression databases

ArrayExpressQ62432.
BgeeQ62432.
CleanExMM_SMAD2.
GenevestigatorQ62432.
GermOnlineENSMUSG00000024563. Mus musculus.

Family and domain databases

InterProIPR013790. Dwarfin.
IPR003619. MAD_homology1_Dwarfin-type.
IPR013019. MAD_homology_MH1.
IPR017855. SMAD_dom-like.
IPR001132. SMAD_dom_Dwarfin-type.
IPR008984. SMAD_FHA_domain.
[Graphical view]
Gene3DG3DSA:3.90.520.10. MAD_MH1. 1 hit.
G3DSA:2.60.200.10. MH2_Dwarfin-type. 1 hit.
PANTHERPTHR13703. Dwarfin. 1 hit.
PfamPF03165. MH1. 1 hit.
PF03166. MH2. 1 hit.
[Graphical view]
SMARTSM00523. DWA. 1 hit.
SM00524. DWB. 1 hit.
[Graphical view]
PROSITEPS51075. MH1. 1 hit.
PS51076. MH2. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio291308.
SOURCESearch...

Entry information

Entry nameSMAD2_MOUSE
AccessionPrimary (citable) accession number: Q62432
Secondary accession number(s): Q6GU18, Q6VP00, Q9D8P6
Entry history
Integrated into UniProtKB/Swiss-Prot: April 27, 2001
Last sequence update: November 14, 2006
Last modified: February 9, 2010
This is version 108 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

MGD cross-references

Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents